Cancer is one of the most complex—and costly—health challenges today. But what if much of what we think we know about cancer care and how to approach it is wrong? From assumptions about treatment uniformity to misconceptions around clinical trials and patient behavior, these myths can lead to missed opportunities for improved outcomes, access to expertise, and eliminating costs from low-value care.
Join us as we expose the most persistent myths in cancer care and reveal what really happens when members receive a diagnosis and undergo treatment. We'll cover:
- Why second opinions are often misunderstood
- Why cancer care isn't standardized today, and what we can do to standardize it
- The surprising truth about clinical trial access and equity
- Why "doctor shopping" in cancer isn't what you think it is
- How outcomes improve when expert guidance is introduced
Whether you're shaping benefits, guiding clinical strategy, making purchasing decisions, or influencing these choices, this conversation will equip you with the insights you need to deliver smarter, more effective cancer care support.
